Last reviewed · How we verify
procalcitonin-guided antibiotic therapy — Competitive Intelligence Brief
phase 3
Infectious Diseases
Small molecule
Live · refreshed every 30 min
Target snapshot
procalcitonin-guided antibiotic therapy (procalcitonin-guided antibiotic therapy) — Capital Medical University. Procalcitonin-guided antibiotic therapy involves using procalcitonin levels to guide the initiation and discontinuation of antibiotic therapy in patients with suspected bacterial infections.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| procalcitonin-guided antibiotic therapy TARGET | procalcitonin-guided antibiotic therapy | Capital Medical University | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- procalcitonin-guided antibiotic therapy CI watch — RSS
- procalcitonin-guided antibiotic therapy CI watch — Atom
- procalcitonin-guided antibiotic therapy CI watch — JSON
- procalcitonin-guided antibiotic therapy alone — RSS
Cite this brief
Drug Landscape (2026). procalcitonin-guided antibiotic therapy — Competitive Intelligence Brief. https://druglandscape.com/ci/procalcitonin-guided-antibiotic-therapy. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab